Researchers at the University of Bath in the UK have developed a wearable belt-like device that can continuously scan the ...

Biosense Webster was deemed to have violated antitrust laws by withholding clinical support to hospitals using Innovative’s ...

Scientists from Kaunas University of Technology (KTU), Lithuania, have developed a system for integrated post-stroke ...

The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

British healthtech company Huma Therapeutics has partnered with Eckuity Capital to lay the foundations for an ‘aggressive’ ...

Intravascular lithotripsy is quickly gaining the attention of the medtech industry’s giants. Yet distinguishing its true clinical promise from the financial buzz is no easy task.

Implantable lens developer STAAR will fund the repurchase using cash on hand and money generated from business operations.

The US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.

The FDA has granted approval to Teal Health’s at-home vaginal sample self-collection device, Teal Wand, for cervical cancer ...

GE HealthCare has gained 501(k) clearance from the US Food and Drug Administration (FDA) for its CleaRecon DL technology.

Ophthalmic technology developer Intalight has received the CE mark for its DREAM OCT (optical coherence tomography) platform ...

The FDA has granted breakthrough device designation for Elucent Medical’s EnVisio X1 In-Body Spatial Intelligence System.